ALNY vs CBNK · P/E 76, rev $1.29B vs P/E 9.9, rev $137.9M
Alnylam Pharmaceuticals Inc (ALNY) versus Capital Bancorp (CBNK) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Capital Bancorp (CBNK) is a banks - regional company listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported CBNK revenue for 2026-06-30 was $137.9M. Net income was $26.3M. CBNK currently screens at market cap $536.9M and trailing P/E 9.9.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. CBNK currently screens at market cap $536.9M and trailing P/E 9.9.
Not investment advice. Open the ALNY and CBNK stock pages for the full models.
Not investment advice.